VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
Zhujun Cao(Shanghai Institute of Hematology), Ren Zhao(Shanghai Institute of Hematology), Shuya Mei(University of Chicago), Yueqiu Gao(Shanghai University), Yiqing Shi(Shanghai Institute of Hematology), Hong Bao(Shanghai Jiao Tong University), Yuan Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Zijia Song(Shanghai Institute of Hematology), Guang Ning(Shanghai Jiao Tong University), Qing Xie(Shanghai Jiao Tong University), Peizhan Chen(National Clinical Research), Yifei Zhang(Shanghai Institute of Hematology), Qin Zhang(Zhejiang Chinese Medical University), Jing Sun(First Affiliated Hospital of Guangzhou Medical University), Weijing Wang(Shanghai Institute of Hematology), Yiping Xu(National Clinical Research), Weiyi Gao(Shanghai Innovative Research Center of Traditional Chinese Medicine), Zhilei Cui(Shanghai Institute of Hematology), Xianmin Meng(Shanghai Public Health Clinical Center), Honglian Gui(Shanghai Institute of Hematology), Haiyan Feng(Shanghai Public Health Clinical Center), Yimei Jiang(Shanghai Institute of Hematology)
Cited by 227
Related Papers
Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis
|Signal Transduction and Targeted Therapy|2020|429
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247